Shao-Wen Tang (Shaowen Tang)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Topics

Systematic Review

Ejection Fraction

Muscular Dystrophy

Top Venues

Journal of clinical pharmacy and therapeutics

Journal of clinical pharmacology

Pharmacogenomics

This page only lists publications with an associated author ORCID identifier.

Publications

Xinyu Chen, Hongqiu Pan, Zhuolu Hao, Honggang Yi, Shao-Wen Tang
Changing Trajectories of Alanine Aminotransferase and Risk of Antituberculosis Drug-Induced Liver Injury in Chinese Patients: A Cohort Study. Journal of clinical pharmacology 64 (7) (2024)
Bing Han, Yiwen He, Min Zhu, Meiling Zhang, Lihuan Lu, Xiaoyan Xu, Xiaomin He, Honggang Yi, Shao-Wen Tang
Association of Gene Polymorphisms and Serum Levels of ALAS1 with the Risk of Anti-Tuberculosis Drug-Induced Liver Injury. Journal of clinical pharmacology (2024)
Xinyu Chen, Hongqiu Pan, Zhuolu Hao, Honggang Yi, Shao-Wen Tang
Changing Trajectories of Alanine Aminotransferase and Risk of Antituberculosis Drug-Induced Liver Injury in Chinese Patients: A Cohort Study. Journal of clinical pharmacology (2024)
Zhuolu Hao, Bing Han, Xinyue Zhou, Hongkai Jian, Xiaomin He, Lihuan Lu, Meiling Zhang, Hongqiu Pan, Honggang Yi, Shao-Wen Tang
Association of DNA methylation, polymorphism and mRNA level of ALAS1 with antituberculosis drug-induced liver injury. Pharmacogenomics (2024)
Xinyu Chen, Zhuolu Hao, Hongqiu Pan, Wenpei Liu, Lihuan Lu, Meiling Zhang, Xiaomin He, Honggang Yi, Shao-Wen Tang
Relationship between common telomere length-related genetic variations, telomere length, and risk of antituberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated Roussel Uclaf Causality Assessment Method. Fundamental & clinical pharmacology (2023)
Xinyu Chen, Zhuolu Hao, Hongqiu Pan, Wenpei Liu, Lihuan Lu, Meiling Zhang, Xiaomin He, Honggang Yi, Shao-Wen Tang
Relationship between common telomere length-related genetic variations, telomere length and risk of anti-tuberculosis drug-induced hepatotoxicity in Chinese Han population: As assessed for causality using the updated RUCAM. Fundamental & clinical pharmacology (2023)
Zhuolu Hao, Meiling Zhang, Xinyu Chen, Min Zhu, Bing Han, Yiwen He, Honggang Yi, Shao-Wen Tang
Genetic variants of the nuclear factor erythroid 2-related factor 2/antioxidant reaction element pathway on the risk of antituberculosis drug-induced liver injury: a systematic review. Pharmacogenomics (2023)
Min Zhu, Xinyu Chen, Zhuolu Hao, Yiwen He, Bing Han, Shao-Wen Tang
SLCO1B1 variants and the risk of antituberculosis drug-induced hepatotoxicity: a systematic review and meta-analysis. Pharmacogenomics (2023)
Xinyu Chen, Zhuolu Hao, Nannan Wang, Jia Zhu, Honggang Yi, Shao-Wen Tang
Genetic Polymorphisms of UDP-Glucuronosyltransferases and Susceptibility to Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis. Journal of tropical medicine 2023 (2023)
Wenpei Liu, Lihuan Lu, Hongqiu Pan, Xiaomin He, Meiling Zhang, Nannan Wang, Jia Zhu, Honggang Yi, Shao-Wen Tang
Heme oxygenase-1 and hemopexin gene polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity in China. Pharmacogenomics 23 (7) (2022)
Meiling Zhang, Jia Zhu, Nannan Wang, Wenpei Liu, Lihuan Lu, Hongqiu Pan, Xiaomin He, Honggang Yi, Shao-Wen Tang
The role of the genetic variant FECH rs11660001 in the occurrence of anti-tuberculosis drug-induced liver injury. Journal of clinical pharmacy and therapeutics 47 (8) (2022)
Jin-Jin Ge, Li Wang, Xueqing Peng, Chi Zhang, Shiqi Zhao, Meng Zhou, Shao-Wen Tang, Hua You
Behaviour model integrated by protection motivation theory and information-motivation-behavioural skills model applying in pregnancy weight management (PrInMAMa): a study protocol for a randomised controlled trial in China. BMJ open 12 (1) (2022)
Nannan Wang, Xinyu Chen, Zhuolu Hao, Jia Guo, Xuwen Wang, Xijing Zhu, Honggang Yi, Qingliang Wang, Shao-Wen Tang
Incidence and Temporal Trend of Antituberculosis Drug-Induced Liver Injury: A Systematic Review and Meta-Analysis. Journal of tropical medicine 2022 (2022)
Qing-Liang Wang, Bing-Hua Huang, Wen-Pei Liu, Hong-Gang Yi, Shao-Wen Tang
Development Trend of Infectious Disease Hospitals in China 2002-2018: A Longitudinal Analysis of National Survey Data. Risk management and healthcare policy 14 (2021)
Miaomiao Yang, Yunliang Qiu, Yanyu Jin, Wenpei Liu, Qingliang Wang, Honggang Yi, Shao-Wen Tang
NR1I2 genetic polymorphisms and the risk of anti-tuberculosis drug-induced hepatotoxicity: A systematic review and meta-analysis. Pharmacology research & perspectives 8 (6) (2021)
Jia Zhu, Wenpei Liu, Meiling Zhang, Lihuan Lu, Hongqiu Pan, Xiaomin He, Nannan Wang, Miaomiao Yang, Honggang Yi, Shao-Wen Tang
A validation study of the UGT1A4 rs2011404 variant and the risk of anti-tuberculosis drug-induced hepatotoxicity in an Eastern Chinese Han population. Journal of clinical pharmacy and therapeutics 46 (5) (2021)
Mi-Ah Han, Dawid Storman, Husam Al-Rammahy, Shao-Wen Tang, Qiukui Hao, Gareth Leung, Maryam Kandi, Romina Moradi, Jessica J Bartoszko, Callum Arnold, Nadia Rehman, Gordon Guyatt
Impact of maternal reproductive factors on cancer risks of offspring: A systematic review and meta-analysis of cohort studies. PloS one 15 (3) (2020)
Bilin Tao, Miaomiao Yang, Hongbo Chen, Hongqiu Pan, Wenpei Liu, Honggang Yi, Shao-Wen Tang
Association of ABO blood group and antituberculosis drug-induced liver injury: A case-control study from a Chinese Han population. Journal of clinical pharmacy and therapeutics 45 (4) (2020)
Shixian Chen, Hongqiu Pan, Yongzhong Chen, Lihuan Lu, Xiaomin He, Hongbo Chen, Ru Chen, Siyan Zhan, Shao-Wen Tang
Association between genetic polymorphisms of NRF2, KEAP1, MAFF, MAFK and anti-tuberculosis drug-induced liver injury: a nested case-control study. Scientific reports 9 (1) (2019)
Lihuan Lu, Bilin Tao, Haixu Wei, Hongbo Chen, Xiaomin He, Hongqiu Pan, Miaomiao Yang, Honggang Yi, Shao-Wen Tang
Relevance of NAT2 genotype to anti-tuberculosis drug-induced hepatotoxicity in a Chinese Han population. The journal of gene medicine 21 (6) (2019)
Fanqi Meng, Zhihua Zhang, Xiaofeng Hou, Zhiyong Qian, Yao Wang, Yanhong Chen, Yilian Wang, Ye Zhou, Zhen Chen, Xiwen Zhang, Jing Yang, Jinlong Zhang, Jianghong Guo, Kebei Li, Lu Chen, Ruijuan Zhuang, Hai Jiang, Weihua Zhou, Shao-Wen Tang, Yongyue Wei, Jiangang Zou
Machine learning for prediction of sudden cardiac death in heart failure patients with low left ventricular ejection fraction: study protocol for a retroprospective multicentre registry in China. BMJ open 9 (5) (2019)
Miaomiao Yang, Hongqiu Pan, Lihuan Lu, Xiaomin He, Hongbo Chen, Bilin Tao, Wenpei Liu, Honggang Yi, Shao-Wen Tang
Home-based Anti-Tuberculosis Treatment Adverse Reactions (HATTAR) study: a protocol for a prospective observational study. BMJ open 9 (3) (2019)
Miaomiao Yang, Haiping Zhang, Bilin Tao, Hongqiu Pan, Lihuan Lu, Honggang Yi, Shao-Wen Tang
Possible association of HMOX1 and NQO1 polymorphisms with anti-tuberculosis drug-induced liver injury: A matched case-control study. Journal of clinical pharmacy and therapeutics 44 (4) (2019)
Xiaomin He, Haiping Zhang, Bilin Tao, Miaomiao Yang, Hongbo Chen, Lihuan Lu, Honggang Yi, Hongqiu Pan, Shao-Wen Tang
The A/A Genotype of XPO1 rs4430924 Is Associated With Higher Risk of Antituberculosis Drug-Induced Hepatotoxicity in Chinese Patients. Journal of clinical pharmacology 59 (7) (2019)